"Comparison of two Anaesthesia Drugs Thiopental and Etomidate during Electroconvulsive Therapy. (ECT) ?

Comparative study between Thiopental and Etomidate on Haemodynamic characteristics during Modified Electroconvulsive Therapy. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073405

Enrollment

110

Registered

2024-09-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F23- Brief psychotic disorder Health Condition 2: F200- Paranoid schizophrenia Health Condition 3: F250- Schizoaffective disorder, bipolartype

Interventions

Intervention1: Etomidate in modified electroconvulsive Therapy: Etomidate 0.2mg /kg[0.2%]injected intravenously and the patient is monitored for 60 minutes after the procedure Intervention2: Thiopent

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 and 2 patients scheduled to under go ECT for various indications . Hemodynamically stable at the time of ECT

Exclusion criteria

Exclusion criteria: Patients refused to participate in the study Allergy to trial drugs

Design outcomes

Primary

Measure	Time frame
To compare the effect of Thiopental and Etomidate on hemodynamic changes during ECTTimepoint: 18 months	—

Secondary

Measure	Time frame
To compare the effect of Thiopental and Etomidate with respect to duration of clinical seizure To compare the recovery time between Thiopental and Etomidate To compare adverse drug reactions between Thiopental and Etomidate Assessment of the cognitive function before and after ECTTimepoint: 18 months	—

Countries

India

Contacts

Public ContactDR .ROSAMMA K J

ATAL BIHARI VAJPAYEE MEDICAL UNIVERSITY

daisyholycross@gmail.com7234028415

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026